MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 230 filers reported holding MYRIAD GENETICS INC in Q4 2019. The put-call ratio across all filers is 1.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,278 | +5.0% | 67 | 0.0% | 0.00% | – |
Q2 2022 | $1,217 | -27.9% | 67 | 0.0% | 0.00% | – |
Q1 2022 | $1,688 | -8.7% | 67 | 0.0% | 0.00% | – |
Q4 2021 | $1,849 | -14.5% | 67 | 0.0% | 0.00% | – |
Q3 2021 | $2,163 | +5.6% | 67 | 0.0% | 0.00% | – |
Q2 2021 | $2,049 | +0.4% | 67 | 0.0% | 0.00% | – |
Q1 2021 | $2,040 | +54.0% | 67 | 0.0% | 0.00% | – |
Q4 2020 | $1,325 | +51.6% | 67 | 0.0% | 0.00% | – |
Q3 2020 | $874 | -38.4% | 67 | -46.4% | 0.00% | – |
Q2 2020 | $1,418 | -20.7% | 125 | 0.0% | 0.00% | – |
Q1 2020 | $1,789 | -47.4% | 125 | 0.0% | 0.00% | – |
Q4 2019 | $3,404 | -4.9% | 125 | 0.0% | 0.00% | – |
Q3 2019 | $3,579 | +3.1% | 125 | 0.0% | 0.00% | – |
Q2 2019 | $3,473 | -16.3% | 125 | 0.0% | 0.00% | – |
Q1 2019 | $4,150 | +14.2% | 125 | 0.0% | 0.00% | – |
Q4 2018 | $3,634 | -36.8% | 125 | 0.0% | 0.00% | -100.0% |
Q3 2018 | $5,750 | +23.1% | 125 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $4,671 | +26.4% | 125 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $3,694 | +60.5% | 125 | +86.6% | 0.00% | – |
Q4 2017 | $2,301 | – | 67 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 4,000,000 | $45,360,000 | 2.60% |
Tieton Capital Management, LLC | 166,441 | $1,887,000 | 2.36% |
S&T BANK/PA | 315,835 | $3,582,000 | 0.82% |
DISCIPLINED GROWTH INVESTORS INC /MN | 2,194,204 | $24,882,000 | 0.60% |
XTX MARKETS LLC | 14,807 | $168,000 | 0.57% |
Glenview Capital Management | 1,810,727 | $20,534,000 | 0.57% |
EARNEST PARTNERS LLC | 4,761,082 | $53,991,000 | 0.51% |
AIMZ Investment Advisors, LLC | 42,685 | $484,000 | 0.31% |
DUALITY ADVISERS, LP | 163,717 | $1,857,000 | 0.17% |
Engineers Gate Manager LP | 219,922 | $2,494,000 | 0.13% |